# FDA Inspection 1164827 - American National Red Cross - March 09, 2022

Source: https://www.keypedia.com/records/fda_inspections/american-national-red-cross/738c9db6-d5fe-41aa-9fa5-56ca694ada16
Source feed: FDA_Inspections

> FDA Inspection 1164827 for American National Red Cross on March 09, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1164827
- Company Name: American National Red Cross
- Inspection Date: 2022-03-09
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1164827 - 2022-03-09](https://www.keypedia.com/records/fda_inspections/american-national-red-cross/cdd8df85-d4dc-44fe-839b-c6316f979cfc)
- [FDA Inspection 1036915 - 2017-12-06](https://www.keypedia.com/records/fda_inspections/american-national-red-cross/61985730-abe1-4b7e-90a4-e8d434b00f92)
- [FDA Inspection 959096 - 2016-02-10](https://www.keypedia.com/records/fda_inspections/american-national-red-cross/4d0f6a09-5cd2-4ccc-8b3e-785902c3751d)
- [FDA Inspection 887438 - 2014-05-02](https://www.keypedia.com/records/fda_inspections/american-national-red-cross/2766c46f-3bb9-4251-a99d-d9cfc8ef6e62)
- [FDA Inspection 774722 - 2012-04-02](https://www.keypedia.com/records/fda_inspections/american-national-red-cross/6328f179-5618-45dd-8a9b-8502b090fb66)

Company: https://www.keypedia.com/companies/american-national-red-cross/622a2b33-0094-4cb5-8751-1d6aa0a008e4

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d